National Task Force against Covid-19 chief implementer and vaccine czar Secretary Carlito Galvez Jr. on Monday disclosed that Moderna has sought an emergency use authority (EUA) from the Food and Drug Administration (FDA).
The application for Moderna’s mRNA-1273 vaccine was made through its healthcare services provider, Zuellig Pharma.
Galvez made the announcement during his virtual report at “Sulong Pilipinas — A Pre-SoNA Economic Development and Infrastructure Clusters Forum.”
“As of now, the FDA issued six EUA to vaccine manufacturers. And this afternoon, Moderna, through Zuellig, has already submitted its application. So today, we have already three WHO emergency utilization leads with Pfizer, AstraZeneca and Johnson and Johnson (J&J),” he said.
The government has procured a total of 13 million Moderna vaccines, while the private sector has ordered 7 million doses of the same brand, Galvez said.
Galvez also reported that as of 25 April, the government has already vaccinated 1.5 million Filipinos, with 1.7 million jabs administered for healthcare workers, senior citizens, and people with comorbidities.
“By June, we expect to accelerate our vaccination supply of 8 to 10 million per month, increasing steadily the expected deliveries of our purchase orders to 20 million doses each month. We are expecting to receive more or less 140 million doses by the end of this year, which excludes the Covax facility’s 44 million doses,” Galvez noted.
The vaccine czar added that in order to simplify and accelerate the government’s vaccination program, authorities started last April the simultaneous administration of vaccines for A1, A2, and A3 categories.
He said that by June, the government can open the vaccination for the productive population, with the government, and economic frontliners, and indigent population categorized as A4 and A5.
“By August, when supply is plenty, we will open the vaccination to the general public,” he revealed.
He added that the Philippines is ranked 4th in terms of vaccination rollout of 1.739 million doses of vaccines administered in the ASEAN region, trailing Myanmar, Singapore and Indonesia.
He said about 1.5 million Sinovac vaccines and 500,000 jabs of Gamaleya are coming in the second quarter of this year.
This May, the country is expecting to have 2 million doses of Sinovac, 2 million of Gamaleya and 194,000 doses of Moderna.
In the 3rd quarter, July deliveries include 3 million of Sinovac, 4 million Gamaleya, 1 million Moderna, 2 million Novavax, 1.5 million J&J, and 2 million doses of AstraZeneca vaccines.
The country also expects 15 to 20 million of various vaccine brands in October; another 15 to 20 million doses in November; and 15 to 20 million doses of vaccines in December. A total of 140 million vaccines are expected in 2021, excluding those from the Covax facility.
Credit belongs to : www.tribune.net.ph